Vimarsana
Biggest News Aggregation in the World

Samir Devani News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Samir Devani. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Samir Devani Today - Breaking & Trending Today

Artificial Heart Maker's Future Seen in Hands of Core Backers - Vimarsana News

Artificial Heart Maker's Future Seen in Hands of Core Backers

Troubled artificial heart maker Carmat is appealing to key shareholders led by Airbus to invest new funds to avoid the collapse of the 30-year-old venture.

Artificial heart maker Carmat's future seen in hands of core backers - Vimarsana News

Artificial heart maker Carmat's future seen in hands of core backers

Troubled artificial heart maker Carmat is appealing to key shareholders led by Airbus to invest new funds to avoid the collapse of the 30-year-old venture dating back to a chance meeting between...

Artificial heart maker Carmat's future seen in hands of core backers - Vimarsana News

Artificial heart maker Carmat's future seen in hands of core backers

By Michal Aleksandrowicz, Tim Hepher and Laura Lenkiewicz PARIS (Reuters) - Troubled artificial heart maker Carmat is appealing to key shareholders le...

Source: whbl.com
Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Call Transcript - Vimarsana News

Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Call Transcript

Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Call Transcript September 21, 2023 Valneva SE misses on earnings expectations. Reported EPS is $0.26 EPS, expectations were $0.36. Operator: Good day, and thank you for standing by. Welcome to the Valneva Half Year 2023 Financial Results Call and Webcast. [Operator Instructions] Please note that today’s conference is being […]

Source: yahoo.com
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q4 2022 Earnings Call Transcript - Vimarsana News

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q4 2022 Earnings Call Transcript

Operator: Good morning, and welcome to the BioXcel Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.